171482-05-6,
(2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine hydrochloride,
(2R,3S)-2-[(1R)-1-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY]-3-(4-FLUOROPHENYL)MORPHOLINE HYDROCHLORIDE,
(2R,3S)-2-{(1R)-1-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY}-3-(4-FLUOROPHENYL)MORPHOLINE HYDROCHLORIDE,
AK-93502,
SCHEMBL14890138,
CTK8B4240,
DTXSID10435824,
ANW-44478,
QC-588,
Aprepitant Impurity 1 Enantiomer HCl,
AKOS015995122,
AKOS015999565,
ACN-028876,
AM84603,
AN-4962,
API0005691,
LS30277,
RL02205,
AC-25506,
DS-17845,
SC-67591,
AX8221324,
DB-001104,
TX-015597,
FT-0686948,
ST24020270,
729A790,
J-500977,
(2R,3S)-2-{(1R)-1-[3,5-BIS(TRIFLUOROMETHYL)PHENYL],
(2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)-ethoxy)-3-(4-fluorophenyl)morpholine hydrochloride,
(2R,3S)-2-{(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholine--hydrogen chloride (1/1),
Arr-[2a(r*), 3a]]-2-[1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl) morpholine hydrochloride,
Morpholine,2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-,hydrochloride, (2R,3S)-,
DWCCMKXSGCKMJF-YNXGUESPSA-N,
CID10116311,
CID 10116311,
(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)morpholine HCl,
(2R,3S)-2-[(1R)-l-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-morpholine hydrochloride,
170729-79-0,